Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:OBORCVE:WEYNYSEARCA:WIL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOBORKraneShares MSCI One Belt One Road Index ETF$23.79+1.3%$22.58$19.04▼$25.32$3.51M0.711,165 shs37 shsWEYLexaGene Holdings Inc,C$0.00C$0.00▼C$0.00N/AN/AN/AN/AWILBarclays Women in Leadership ETN$86.93$86.93$78.50▼$103.13$3.65MN/A450 shsN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOBORKraneShares MSCI One Belt One Road Index ETF+1.28%+2.19%+4.62%+10.19%+10.55%WILBarclays Women in Leadership ETN0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationOBORKraneShares MSCI One Belt One Road Index ETFN/AN/AN/AN/AN/AN/AN/AN/AWEYLexaGene Holdings Inc,N/AN/AN/AN/AN/AN/AN/AN/AWILBarclays Women in Leadership ETNN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOBORKraneShares MSCI One Belt One Road Index ETF 1.33Sell$23.79N/AWEYLexaGene Holdings Inc, 0.00N/AN/AN/AWILBarclays Women in Leadership ETN 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOBORKraneShares MSCI One Belt One Road Index ETFN/AN/AN/AN/AN/AN/AWEYLexaGene Holdings Inc,N/AN/AN/AN/AN/AN/AWILBarclays Women in Leadership ETNN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOBORKraneShares MSCI One Belt One Road Index ETFN/AN/A10.44∞N/AN/AN/AN/AN/AWEYLexaGene Holdings Inc,N/AN/A0.00N/AN/AN/AN/AN/AN/AWILBarclays Women in Leadership ETNN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOBORKraneShares MSCI One Belt One Road Index ETF$0.813.40%N/AN/AN/AWEYLexaGene Holdings Inc,N/AN/AN/AN/AN/AWILBarclays Women in Leadership ETNN/A0.00%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOBORKraneShares MSCI One Belt One Road Index ETFN/AWEYLexaGene Holdings Inc,N/AWILBarclays Women in Leadership ETNN/AInsider OwnershipCompanyInsider OwnershipOBORKraneShares MSCI One Belt One Road Index ETFN/AWEYLexaGene Holdings Inc,N/AWILBarclays Women in Leadership ETNN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOBORKraneShares MSCI One Belt One Road Index ETFN/A150,000N/ANot OptionableWEYLexaGene Holdings Inc,N/AN/AN/ANot OptionableWILBarclays Women in Leadership ETN2,02042,000N/ANot OptionableWIL, WEY, OBOR, and GFHG HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBest Dollar Store Stock to Buy: Dollar Tree or Dollar General? By Thomas Hughes | June 5, 2025View Best Dollar Store Stock to Buy: Dollar Tree or Dollar General? Analysts Supercharge AMD Stock Ahead of Q2 AI CatalystBy Thomas Hughes | June 26, 2025View Analysts Supercharge AMD Stock Ahead of Q2 AI CatalystNVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s WhyBy Thomas Hughes | May 29, 2025View NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s WhyRivian vs. Lucid: Who’s Best Positioned to Steal Tesla’s Thunder?By Nathan Reiff | June 20, 2025View Rivian vs. Lucid: Who’s Best Positioned to Steal Tesla’s Thunder?WIL, WEY, OBOR, and GFHG Company DescriptionsKraneShares MSCI One Belt One Road Index ETF NYSEARCA:OBOR$23.79 +0.30 (+1.28%) As of 06/26/2025 04:10 PM EasternThe KraneShares MSCI One Belt One Road Index ETF (OBOR) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected, tier-weighted index of companies likely to benefit from China's One Belt, One Road initiative. OBOR was launched on Sep 7, 2017 and is managed by KraneShares.LexaGene Holdings Inc, CVE:WEYLexaGene Holdings Inc, formerly Wolfeye Resource Corp, is a Canada-based biotechnology company. The Company focuses on building automated instruments for rapid pathogen detection. The Company's instrument operates a layperson, allowing the Company to place these instruments at the site of collection, whether inside of food processing plants or inside hospitals.Barclays Women in Leadership ETN NYSEARCA:WIL$86.93 0.00 (0.00%) As of 12/23/2022 More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
